Hormone therapy for metastatic prostate cancer can improve quality of life and longevity for those receiving treatment.

Approximately 75% of patients with bladder cancer present with non–muscle invasive bladder cancer (NMIBC). 1 The recommended therapy for NMIBC is transurethral resection of bladder tumor (TURBT) and ...

A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene—commonly altered in prostate ...

THURSDAY, July 10, 2025 (HealthDay News) -- Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a study published online in ...

Bladder cancer radiotherapy has evolved significantly over recent years, with adaptive treatment techniques offering a promising approach to overcome the inherent challenges associated with ...

Non-muscle invasive bladder cancer is a relatively early stage cancer that has not spread to the muscle layer of the bladder wall, accounting for about 70% of all bladder cancer patients. Although ...

The FDA has eliminated a safety monitoring requirement and eased certain restrictions that had been in place since CAR T-therapies first reached the market in 2017. The agency and financial ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. | The Fierce Biotech Fundraising Tracker records ...